Researchers say SNG001 can reduce need for ventilation and improve survival chances
Trials of an experimental drug inhaled by patients have found a significant reduction in hospital patients with Covid-19 needing to be put on a ventilator or dying from the disease, according to researchers
The drug, called SNG001, is delivered via an inhaler and is based on interferon beta, a protein produced naturally in the body that plays an important role in coordinating the body’s antiviral response.
Source: https://www.theguardian.com/world/2020/jul/20/trial-of-covid-19-coronavirus-drug-given-via-inhaler-sng001-very-promising-say-scientists
Droolin’ Dog sniffed out this story and shared it with you.
The Article Was Written/Published By: Nicola Davis
! #Headlines, #CoronaVirus, #Health, #Medicine, #Newsfeed, #Trending, #Coronavirus, #News, #Science
No comments:
Post a Comment